Cardiome Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.11.17	Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference (PR Newswire)
15.11.17	Home Capital Reports Third Quarter 2017 Results (PR Newswire)
14.11.17	Cardiome Reports Third Quarter 2017 Financial Results (PR Newswire)
14.11.17	Cardiome Reports Third Quarter 2017 Financial Results (PR Newswire)
08.11.17	Crombie REIT Reports Third Quarter 2017 Results (PR Newswire)
07.11.17	Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14 (PR Newswire)
07.11.17	Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14 (PR Newswire)
06.11.17	Health Canada Approves IMFINZI® (durvalumab) for Previously Treated Patients with Advanced Bladder Cancer (PR Newswire)
05.11.17	Amy Millar Claims First Canadian Show Jumping Championship Title at Toronto's Royal Horse Show (PR Newswire)
02.11.17	Cardiome Announces Expansion of Global Geographic Footprint for Brinavess® (PR Newswire)
02.11.17	Cardiome Announces Expansion of Global Geographic Footprint for Brinavess® (PR Newswire)
30.10.17	Cardiome Announces Commercial Launch of Xydalba™ in Three New European Geographies (PR Newswire)
30.10.17	Cardiome Announces Commercial Launch of Xydalba™ in Three New European Geographies (PR Newswire)
27.10.17	JACOB'S CREEK(TM) Launches 'DOUBLE BARREL' Wine Campaign Narrated By Chris Hemsworth (PR Newswire)
27.10.17	Norbord Reports Third Quarter 2017 Results; Increases Quarterly Dividend (PR Newswire)
23.10.17	Canadian Broker Network announces the 2017 Underwriter Awards (PR Newswire)
04.10.17	REKO reports year end profit (PR Newswire)
03.10.17	Four innovative businesses from the Rimouski-Neigette and La Mitis RCMs can continue to expand (PR Newswire)
03.10.17	Montreal startup Soul.City launches its city discovery app in New York and San Francisco! (PR Newswire)
02.10.17	iA Clarington launches global and emerging market funds for income-seeking investors (PR Newswire)
29.09.17	RBC Investor & Treasury Services maintains global fund administrator position for fifth year running (PR Newswire)
27.09.17	GMP Securities announces dedicated blockchain team (PR Newswire)
27.09.17	Traditional Chinese Medicine Brand GuangYuYuan to make Global Debut at Paris Fashion Week (PR Newswire)
22.09.17	Frazer Bourchier Steps Down as Nevsun Chief Operating Officer (AMENDED) (PR Newswire)
12.09.17	Cardiome Announces Agreement with Basilea for Distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and Israel (PR Newswire)
05.09.17	Cardiome to Present at the Rodman & Renshaw 19th Annual Global Investment Conference (PR Newswire)
30.08.17	New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS® (PR Newswire)
23.08.17	Gainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA... (RTTNews)
22.08.17	FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed (RTTNews)
21.08.17	FDA: Cardiome's BRINAVESS Data Would Not Be Sufficient To Support Resubmission (RTTNews)
21.08.17	Cardiome Provides U.S. Regulatory Update For BRINAVESS (PR Newswire)
08.08.17	Cardiome Reports Second Quarter 2017 Financial Results (PR Newswire)
01.08.17	Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8 (PR Newswire)
17.07.17	Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen (PR Newswire)
03.07.17	Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension (PR Newswire)
23.06.17	Cardiome Pharma Corp. Announces Voting Results (PR Newswire)
21.06.17	Cardiome Announces Licensing Agreement for XYDALBA™ (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel (PR Newswire)
16.05.17	Cardiome Reports Changes To Senior Management Team (PR Newswire)
15.05.17	Cardiome Reports First Quarter 2017 Financial Results (PR Newswire)
15.05.17	Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds (PR Newswire)
08.05.17	Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15 (PR Newswire)
27.04.17	Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference (PR Newswire)
06.04.17	Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study (PR Newswire)
03.04.17	Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review (PR Newswire)
14.03.17	Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS (PR Newswire)
07.03.17	Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
03.03.17	Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in France (PR Newswire)
27.02.17	Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7 (PR Newswire)
20.12.16	Cardiome Announces Commercial Launch of XYDALBA™ (dalbavancin) in Germany (PR Newswire)
08.12.16	Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in the UK (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	97.61	0.60 %	K V
Swisscom	510.00	0.59 %	K V
Swiss Re	145.20	0.52 %	K V
Swiss Life Hldg	785.20	0.00 %	K V
Sonova Hldg	292.00	-0.03 %	K V
Sika	227.40	-1.56 %	K V
Part Grp Hldg	1’318.00	-1.72 %	K V
Alcon	83.00	-1.80 %	K V
UBS Group	30.09	-2.05 %	K V
Kuehne+Nagel Int	206.90	-4.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cardiome Pharma Corp

Aktien Top/Flop

Meistgelesene Nachrichten